COMP <GO>
AGCO vs TMO // ENTERPRISE SCALE & MARKET CAP
AGCO Corporation (NYSE) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: AGCO 5
— TMO 10
▲ ENTERPRISE SCALE & MARKET CAP LEADER: TMO
LAST: $110.91 (+2.85%) • MKT CAP: $7.55B
market-cap
$7.55B
LAST: $697.00 (-1.72%) • MKT CAP: $262.22B
market-cap
$262.22B
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (AGCO VS. TMO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | AGCO | TMO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 25.50% | 41.00% | -15.50 | TMO | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 8.20% | 9.30% | -1.10 | TMO | /roic <GO> |
| EV/EBITDA & P/E Valuation | 11.2x | 30.4x | -19.20 | AGCO | /valuation <GO> |
| Free Cash Flow Yield | 9.80% | 2.40% | +7.40 | AGCO | /fcf-yield <GO> |
| Operating Margin | 5.90% | 17.40% | -11.50 | TMO | /operating-margins <GO> |
| Net Profit Margin | 7.20% | 15.10% | -7.90 | TMO | /net-margins <GO> |
| Revenue Growth (YoY) | -13.50% | 3.90% | -17.40 | TMO | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 1.15% | 0.24% | +0.91 | AGCO | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.48 | 4.50 | -2.02 | TMO | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 8/9 | -1.00 | TMO | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 7.20% | 6.70% | +0.50 | TMO | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 54.1 | 59.1 | -5.06 | TMO | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.08 | 0.94 | +0.14 | AGCO | /macro-sensitivity <GO> |
| Forward P/E Multiple | 9.7x | 36.3x | -26.60 | AGCO | /forward-pe <GO> |
| Enterprise Scale & Market Cap ACTIVE | $7.55B | $262.22B | -$254.67B | TMO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | AGCO REV | TMO REV | AGCO GROSS % | TMO GROSS % | AGCO FCF | TMO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $10.08B | $44.56B | 25.5% | 44.0% | $740.2M | $6.29B |
| FY 2024 | $11.66B | $42.88B | 24.9% | 44.0% | $296.6M | $7.27B |
| FY 2023 | $14.41B | $42.86B | 44.0% | 44.0% | $454.5M | $6.48B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
AGCO // BETA 1.08
TMO // BETA 0.94